bpc-157 fda status just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank FDA's Overreach on Compounded Peptides

Ahmed et al

These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying

LOOK BETTER AND FEEL BETTER There are many ways to treat your underlying wellness issues and restore your health and vitality

Each bottle includes: 25 precision-measured tablets High purity formulation Stable tablet structure Easy storage compatibility Reliable dosing accuracy Reduced preparation time These features help research teams maintain consistent protocols

Conversely, given the strong association between NAFLD and diabetes, it is also recommended that all people with NAFLD be screened for diabetes